Represented by Kathleen Rice (D-N.Y.?) Let her know you oppose her

[elleng]

opposition to Dem party’s plan to lower drug prices, creating a significant roadblock for Democrats’ desired $3.5 trillion tax and spending package.

There is no good reason drug prices should not be negotiated between insurance companies and pharma companies. Those representing Federal employees have negotiated drug prices for many years, resulting in excellent, affordable prices.

The Federal Employees Health Benefits (FEHB) program is the largest employer-sponsored health insurance program in the world, covering more than 8 million Federal employees, retirees, former employees, family members, and former spouses.

https://www.energy.gov/hc/federal-employee-health-benefits-fehb

[Budi]

1. Just what was her & the couple others' reason for this?

I can't find it, if they even gave a reason.

[elleng]

2. Scott Peters (CA) said

'If we signal to investors through price setting that they may not be able to recoup their investment not only for their successes, but also their failures, they’ll invest elsewhere & we may well lose our ability to find cures to the toughest and rarest chronic diseases. (9/12)'

Currying favor with pharma.

[Budi]

3. Ugh. I don't have a reply to Peter's explanation. Nothing.

Can we check where Peters' personal investments are?

That's the reason he gave? !!!

Who's running against him?
🤬